"interview journal"

Interview with Prof. J.M.K. Murthy, President of the Indian Academy of Neurology (IAN)

Prof. Carlos Rieder, President of the Brazilian Academy of Neurology is interviewed by Prof. D. Muresanu and Prof. T. von Oertzen, co-chairs of the EAN Communication Committee

COVID-19 around the World: Clinician interviews on experience and impact of the virus (Japan)

Elena Moro interviews Dr. Prashanth LK

Prof. D. Muresanu interviews Prof. Michael Brainin, President of the World Stroke Organization (WSO)

Prof. Dafin Muresanu, Chair of the EAN Communication Committee interviews Dr. Bart van der Worp, President of the European Stroke Organisation.

Dr. Tom Jenkins, Chair of the EAN e-Communication Committee interviews Prof. Didier Leys, Editor in Chief of the European Journal of Neurology

The former co-chairs of the Scientific Panel on Mutliple Sclerosis, Gaincarlo  Comi and Ludwig Kappos, explain the work and aims of the panel.

Dear Prof. McNicholas, thank you for accepting this interview. In light of the work towards an MoU with EAN, we would like to introduce the ESRS to the EANpages readers.

Prof. David B. Vodušek (DVB): Dear Prof. Zuberi I congratulate you with your new position as President of the EPNS. EAN addresses clinical neurology and needs to broaden its spectrum also towards clinical neuro-pediatrics. Kindly introduce the EPNS and its work to the readers of the EAN Pages Prof. Sameer Zuberi (SZ): Thank you. It is a special honour and a privilege for me to be elected as President of the EPNS. Our outgoing President, Lieven Lagae, deserves an enormous thank you from all of us— for guiding the society so ably.

Antonio Federico (AF): Dear Professor, you founded Orphanet and gave a great contribution on the development of information about Rare Diseases in Europe. Can you summarize your past activities and the difficulties you had? Segolene Aymé (SA): That is a long story as I started to build a database of genetic diseases and of malformation syndromes described in the literature, in the mid-seventies, when I started as a clinician in medical genetics, lost in diagnosing most of the patients attending our clinic in Marseilles.

David B. Vodušek (DBV): UEMS-Union Européenne des Médecins Spécialistes/European Union of Medical Specialists has already a long experience with accreditation of international CME in Europe. Please inform about the situation of CME in European countries. What are the differences between CME and CPD? Nathalie Paulus (NP): One of the aims of the UEMS has always been to try and harmonise CME/CPD in Europe. In this respect the UEMS regularly conducts surveys in order to explore the state of play of CME/CPD in Europe. The latest survey dates back to 2014.

David B. Vodušek (DBV): When looking back at your long and varied career, can you tell us what was crucial for you to choose neurology as your specialty, and headache as your primary research field of interest?  Jes Olesen (JO): Already as a medical student, I was interested in neurology. I thought at that time – and I still think so today – that the brain is by far the most interesting organ in a human being.

David B. Vodušek (DBV): The Scientific Panel for Health – SPH is an official and unique panel of the EC within H2020. Can you introduce the SPH to the readers of EAN and explain its tasks? Karin Sipido (KS): The European Commission’s Scientific Panel for Health is a science-led expert group based on the provisions of the Horizon2020 Specific Programme.

Gunhild Waldemar (GW): The ageing European population and the steep rise in people affected by Alzheimer’s Disease bring the EADC at the forefront of scientific research. Can you briefly introduce the EADC and its structure to the readers of EANpages? Bengt Winblad (BW): The EADC (European Alzheimer Disease Consortium) is a fully functional network of 66 European centres of clinical and biomedical research excellence, working and leading innovative research in the field of AD and related dementias (www.eadc.info).